Advertisement

Neurological Sciences

, Volume 40, Issue 2, pp 261–268 | Cite as

Neurological presentations of Bartonella henselae infection

  • B. CannetiEmail author
  • I. Cabo-López
  • A. Puy-Núñez
  • J. C. García García
  • F. J. Cores
  • M. Trigo
  • A. P. Suárez-Gil
  • A. Rodriguez-Regal
Original Article

Abstract

Objective

Neurological symptoms in patients with cat-scratch disease (CSD) have been rarely reported. The aim of this study is to analyze the frequency of neurological CSD (NCSD) and describe the disease clinical presentation, management and outcome.

Material and methods

We retrospectively selected patients with a CSD syndrome and Bartonella IgG titers > 1:256. Data regarding epidemiological, clinical, management, and follow-up features were analyzed and discussed. A comparison between NCSD and non-neurological CSD (NNCSD) was established.

Results

Thirty-nine CSD patients were selected. NCSD frequency was 10.25%. No children were found affected in the NCSD group. A 65.7% of NNCSD and the entirety of the NCSD group had a history of cat exposure. Immunosuppression was only present in the NNCSD group (8.6%). NCSD presentations were as follows: isolated aseptic meningitis (25%), neuroretinitis (50%), and isolated optic neuritis (25%). A greater proportion of patients in the NCSD group had fever and raised levels of acute phase reactants and white blood cells. 85.7% of NNCSD had a complete recovery, whereas only 50% of the NCSD patients experienced a full recovery.

Conclusion

NCSD may be a distinctive group compared to NNCSD due to its later age of presentation, the more intense systemic response, and the poorer outcome.

Keywords

Bartonella Neurobartonellosis Cat-scratch disease Neuroretinitis 

References

  1. 1.
    Huarcaya E, Maguina C, Merello J, Cok J, Birtles R, Infante B, Vidal J, Tello A, Ventosilla P (2002) A prospective study of cat-scratch disease in Lima-Peru. Rev Inst Med Trop Sao Paulo 44(6):325–330PubMedCrossRefGoogle Scholar
  2. 2.
    Murakami K, Tsukahara M, Tsuneoka H, Iino H, Ishida C, Tsujino K, Umeda A, Furuya T, Kawauchi S, Sasaki K (2002) Cat scratch disease: analysis of 130 seropositive cases. J Infect Chemother 8(4):349–352PubMedCrossRefGoogle Scholar
  3. 3.
    Anderson BE, Neuman MA (1997) Bartonella spp. as emerging human pathogens. Clin Microbiol Rev 10(2):203–219PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Kooli I, Loussaief C, Ben Brahim H, Aouem A, Toumi A, Chakroun M (2014) Bartonella quintana meningoencephalitis in an immunocompetent: rare case. Pathol Biol (Paris) 62(6):342–344CrossRefGoogle Scholar
  5. 5.
    Baylor P, Garoufi A, Karpathios T, Lutz J, Mogelof J, Moseley D (2007) Transverse myelitis in 2 patients with Bartonella henselae infection (cat scratch disease). Clin Infect Dis 45(4):e42–e45PubMedCrossRefGoogle Scholar
  6. 6.
    Carman KB, Yimenicioglu S, Ekici A, Yakut A, Dinleyici EC (2013) Co-existence of acute transverse myelitis and Guillain-Barre syndrome associated with Bartonella henselae infection. Paediatr Int Child Health 33(3):190–192PubMedCrossRefGoogle Scholar
  7. 7.
    Klotz SA, Ianas V, Elliott SP (2011) Cat-scratch disease. Am Fam Physician 83(2):152–155PubMedGoogle Scholar
  8. 8.
    Garcia Garcia JC, Nunez Fernandez MJ, Portillo Barrio A, Oteo Revuelta JA (2017) Cat-scratch disease presenting as parotid gland abscess and aseptic meningitis. Enferm Infecc Microbiol Clin 35(1):58–59PubMedCrossRefGoogle Scholar
  9. 9.
    Ulug M (2015) Evaluation of cat scratch disease cases reported from Turkey between 1996 and 2013 and review of the literature. Cent Eur J Public Health 23(2):146–151Google Scholar
  10. 10.
    Hamilton DH, Zangwill KM, Hadler JL, Cartter ML (1995) Cat-scratch disease--Connecticut, 1992-1993. J Infect Dis 172(2):570–573PubMedCrossRefGoogle Scholar
  11. 11.
    Tan CL, Fhun LC, Tai EL, Abdul Gani NH, Muhammed J, Tuan Jaafar TN, Ahmad Tajudin LS, Wan Hitam WH (2017) Clinical profile and visual outcome of ocular bartonellosis in Malaysia. Journal of tropical medicine 2017:7946123PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Wong MT, Dolan MJ, Lattuada CP Jr, Regnery RL, Garcia ML, Mokulis EC, LaBarre RA, Ascher DP, Delmar JA, Kelly JW et al (1995) Neuroretinitis, aseptic meningitis, and lymphadenitis associated with Bartonella (Rochalimaea) henselae infection in immunocompetent patients and patients infected with human immunodeficiency virus type 1. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 21(2):352–360CrossRefGoogle Scholar
  13. 13.
    Sander A, Posselt M, Oberle K, Bredt W (1998) Seroprevalence of antibodies to Bartonella henselae in patients with cat scratch disease and in healthy controls: evaluation and comparison of two commercial serological tests. Clin Diagn Lab Immunol 5(4):486–490PubMedPubMedCentralGoogle Scholar
  14. 14.
    Bergmans AM, Peeters MF, Schellekens JF, Vos MC, Sabbe LJ, Ossewaarde JM, Verbakel H, Hooft HJ, Schouls LM (1997) Pitfalls and fallacies of cat scratch disease serology: evaluation of Bartonella henselae-based indirect fluorescence assay and enzyme-linked immunoassay. J Clin Microbiol 35(8):1931–1937PubMedPubMedCentralGoogle Scholar
  15. 15.
    Carithers HA, Margileth AM (1991) Cat-scratch disease. Acute encephalopathy and other neurologic manifestations. American journal of diseases of children (1960) 145(1):98–101CrossRefGoogle Scholar
  16. 16.
    Breitschwerdt EB, Sontakke S, Hopkins S (2012) Neurological manifestations of bartonellosis in immunocompetent patients: a composite of reports from 2005–2012. J Neuro-Oncol 3:1–15Google Scholar
  17. 17.
    Deschasse C, Bielefeld P, Muselier A, Bour JB, Besancenot JF, Garcher CC, Bron AM (2016) Eye and cat scratch disease: a case series. J Fr Ophtalmol 39(2):164–170PubMedCrossRefGoogle Scholar
  18. 18.
    Raihan AR, Zunaina E, Wan-Hazabbah WH, Adil H, Lakana-Kumar T (2014) Neuroretinitis in ocular bartonellosis: a case series. Clin Ophthalmol (Auckland, NZ) 8:1459–1466Google Scholar
  19. 19.
    Reed JB, Scales DK, Wong MT, Lattuada CP Jr, Dolan MJ, Schwab IR (1998) Bartonella henselae neuroretinitis in cat scratch disease. Diagnosis, management, and sequelae. Ophthalmology 105(3):459–466PubMedCrossRefGoogle Scholar
  20. 20.
    Curi AL, Machado D, Heringer G, Campos WR, Lamas C, Rozental T, Gutierres A, Orefice F, Lemos E (2010) Cat-scratch disease: ocular manifestations and visual outcome. Int Ophthalmol 30(5):553–558PubMedCrossRefGoogle Scholar
  21. 21.
    Chi SL, Stinnett S, Eggenberger E, Foroozan R, Golnik K, Lee MS, Bhatti MT (2012) Clinical characteristics in 53 patients with cat scratch optic neuropathy. Ophthalmology 119(1):183–187PubMedCrossRefGoogle Scholar
  22. 22.
    Ben-Ami R, Ephros M, Avidor B, Katchman E, Varon M, Leibowitz C, Comaneshter D, Giladi M (2005) Cat-scratch disease in elderly patients. Clin Infect Dis 41(7):969–974PubMedCrossRefGoogle Scholar
  23. 23.
    Florin TA, Zaoutis TE, Zaoutis LB (2008) Beyond cat scratch disease: widening spectrum of Bartonella henselae infection. Pediatrics 121(5):e1413–e1425PubMedCrossRefGoogle Scholar
  24. 24.
    Oray M, Onal S, Koc Akbay A, Tugal Tutkun I (2017) Diverse clinical signs of ocular involvement in cat scratch disease. Turk J Ophthalmol 47(1):9–17PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Ak R, Doganay F, Akoglu EU, Ozturk TC (2015) A challenging differential diagnosis of optic neuropathy in ED: CSD. BMJ Case Rep 2015:bcr2015210252PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Gan JJ, Mandell AM, Otis JA, Holmuhamedova M, Perloff MD (2011) Suspecting optic neuritis, diagnosing Bartonella cat scratch disease. Arch Neurol 68(1):122–126PubMedCrossRefGoogle Scholar
  27. 27.
    Vodopivec I, Shah CP, Prasad S, Cohen AB (2015) Teaching NeuroImages: cat-scratch optic neuropathy without neuroretinitis. Neurology 84(24):e204–e205PubMedCrossRefGoogle Scholar
  28. 28.
    Schmalfuss IM, Dean CW, Sistrom C, Bhatti MT (2005) Optic neuropathy secondary to cat scratch disease: distinguishing MR imaging features from other types of optic neuropathies. AJNR Am J Neuroradiol 26(6):1310–1316PubMedGoogle Scholar
  29. 29.
    Stevens H (1952) Cat-scratch fever encephalitis. A.M.A. American journal of diseases of children 84(2):218–222PubMedGoogle Scholar
  30. 30.
    Genizi J, Kasis I, Schif A, Shahar E (2007) Effect of high-dose methyl-prednisolone on brainstem encephalopathy and basal ganglia impairment complicating cat scratch disease. Brain Dev 29(6):377–379PubMedCrossRefGoogle Scholar
  31. 31.
    Anbu AT, Foulerton M, McMaster P, Bakalinova D (2003) Basal ganglia involvement in a child with cat-scratch disease. Pediatr Infect Dis J 22(10):931–932PubMedCrossRefGoogle Scholar
  32. 32.
    Balakrishnan N, Ericson M, Maggi R, Breitschwerdt EB (2016) Vasculitis, cerebral infarction and persistent Bartonella henselae infection in a child. Parasit Vectors 9(1):254PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Schuster AL, Honeycutt TC, Hamrick HJ (2016) Status epilepticus due to cat scratch disease: recognition, diagnosis, and thoughts on pathogenesis. Pediatr Emerg Care 32(11):789–791PubMedCrossRefGoogle Scholar
  34. 34.
    Lucey D, Dolan MJ, Moss CW, Garcia M, Hollis DG, Wegner S, Morgan G, Almeida R, Leong D, Greisen KS, Welch DF, Slater LN (1992) Relapsing illness due to Rochalimaea henselae in immunocompetent hosts: implication for therapy and new epidemiological associations. Clin Infect Dis 14(3):683–688PubMedCrossRefGoogle Scholar
  35. 35.
    Pinto VL Jr, Curi AL, Pinto Ada S, Nunes EP, Teixeira Mde L, Rozental T, Favacho AR, Castro EL, Boia MN (2008) Cat scratch disease complicated with aseptic meningitis and neuroretinitis. Braz J Infect Dis 12(2):158–160PubMedCrossRefGoogle Scholar
  36. 36.
    Brinar VV, Habek M (2010) Rare infections mimicking MS. Clin Neurol Neurosurg 112(7):625–628PubMedCrossRefGoogle Scholar
  37. 37.
    Marienfeld CB, Dicapua DB, Sze GK, Goldstein JM (2010) Expressive aphasia as a presentation of encephalitis with Bartonella henselae infection in an immunocompetent adult. Yale J Biol Med 83(2):67–71PubMedPubMedCentralGoogle Scholar
  38. 38.
    Salgado CD, Weisse ME (2000) Transverse myelitis associated with probable cat-scratch disease in a previously healthy pediatric patient. Clin Infect Dis 31(2):609–611PubMedCrossRefGoogle Scholar
  39. 39.
    Schaller JL, Burkland GA, Langhoff PJ (2007) Do bartonella infections cause agitation, panic disorder, and treatment-resistant depression? MedGenMed 9, 54(3)Google Scholar
  40. 40.
    Breitschwerdt EB, Maggi RG, Nicholson WL, Cherry NA, Woods CW (2008) Bartonella sp. bacteremia in patients with neurological and neurocognitive dysfunction. J Clin Microbiol 46(9):2856–2861PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Walter RS, Eppes SC (1998) Cat scratch disease presenting with peripheral facial nerve paralysis. Pediatrics 101(5):E13PubMedCrossRefGoogle Scholar
  42. 42.
    Ganesan K, Mizen K (2005) Cat scratch disease: an unusual cause of facial palsy and partial ptosis: case report. J Oral Maxillofac Surg 63(6):869–872PubMedCrossRefGoogle Scholar
  43. 43.
    Thompson PK, Vaphiades MS, Saccente M (1999) Cat-scratch disease presenting as neuroretinitis and peripheral facial palsy. J Neuroophthalmol 19(4):240–241PubMedCrossRefGoogle Scholar
  44. 44.
    Massei F, Gori L, Taddeucci G, Macchia P, Maggiore G (2006) Bartonella henselae infection associated with Guillain-Barre syndrome. Pediatr Infect Dis J 25(1):90–91PubMedCrossRefGoogle Scholar
  45. 45.
    Lamps LW, Scott MA (2004) Cat-scratch disease: historic, clinical, and pathologic perspectives. Am J Clin Pathol 121(Suppl):S71–S80PubMedGoogle Scholar
  46. 46.
    Prutsky G, Domecq JP, Mori L, Bebko S, Matzumura M, Sabouni A, Shahrour A, Erwin PJ, Boyce TG, Montori VM, Malaga G, Murad MH (2013) Treatment outcomes of human bartonellosis: a systematic review and meta-analysis. Int J Infect Dis 17(10):e811–e819PubMedCrossRefGoogle Scholar
  47. 47.
    Rosen BS, Barry CJ, Nicoll AM, Constable IJ (1999) Conservative management of documented neuroretinitis in cat scratch disease associated with Bartonella henselae infection. Aust N Z J Ophthalmol 27(2):153–156PubMedCrossRefGoogle Scholar
  48. 48.
    Ray S, Gragoudas E (2001) Neuroretinitis. Int Ophthalmol Clin 41(1):83–102PubMedCrossRefGoogle Scholar
  49. 49.
    Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ, Raoult D (2004) Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 48(6):1921–1933PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Bass JW, Freitas BC, Freitas AD, Sisler CL, Chan DS, Vincent JM, Person DA, Claybaugh JR, Wittler RR, Weisse ME, Regnery RL, Slater LN (1998) Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatr Infect Dis J 17(6):447–452PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Neurology DepartmentComplejo Hospitalario Universitario PontevedraPontevedraSpain
  2. 2.Internal Medicine DepartmentComplejo Hospitalario Universitario PontevedraPontevedraSpain
  3. 3.Ophthalmology DepartmentComplejo Hospitalario Universitario PontevedraPontevedraSpain
  4. 4.Microbiology DepartmentComplejo Hospitalario Universitario PontevedraPontevedraSpain

Personalised recommendations